// App-Quantinova.ai

3113 : Impact of Parental Donor Type On Outcomes After HLA-Matched and HLA-Mismatched T-Cell-Replete Hematopoietic Cell Transplantation for Patients with Leukemia: A Retrospective Cohort Study.

Researchers

Presenter

  • Junya Kanda

Principal Investigators

  • Jiro Inagaki

  • Masami Inoue

  • Katsuyoshi Koh

  • Atsushi Kikuta

  • Hiromasa Yabe

  • Junji Tanaka

  • Yoshiko Atsuta

  • Yoshinobu Kanda

Medical Centers

  • Department of Radiology, Okayama University Graduate School of Medicine, Okayama, Japan

  • Haematology/Oncology, Osaka Medical Center And Research Institute For Maternal And Child Health, Izumi, Osaka, Japan

  • Department of Pediatric Oncology, Fukushima Medical University, Fukushima, Japan

  • Department of Surgery, Saitama Medical Center, Jichi Medical University, Saitama, Japan

  • Department of Cell Transplantation and Regenerative Medicine, Tokai University School of Medicine, Isehara, Japan

  • Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan

  • Hematopoietic Stem Cell Transplantation Data Management / Biostatistics, Nagoya University School of Medicine, Nagoya, Japan

  • Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan

  • Department of Hematology/Oncology, Saitama Childrens Medical Center, Saitama, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Acute lymphoblastic leukemia

  • Chronic Myelogenous Leukemia

  • Graft-versus-host disease

  • Alpha-thalassemia myelodysplasia syndrome

  • Acute myelocytic leukemia

Biomarkers

  • Hematocrit

  • Major Histocompatibility Complex, Class I, A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved